Cargando…
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Menopausal symptoms (eg, hot flushes and vaginal symptoms) are common, often bothersome, and can adversely impact women’s sexual functioning, relationships, and quality of life. Estrogen–progestin therapy was previously considered the standard care for hormone therapy (HT) for managing these symptom...
Autores principales: | Kagan, Risa, Goldstein, Steven R, Pickar, James H, Komm, Barry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827910/ https://www.ncbi.nlm.nih.gov/pubmed/27103814 http://dx.doi.org/10.2147/TCRM.S63833 |
Ejemplares similares
-
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
por: Mirkin, Sebastian, et al.
Publicado: (2013) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women
por: Lovre, Dragana, et al.
Publicado: (2019) -
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013)